These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

98 related articles for article (PubMed ID: 526949)

  • 21. Tamoxifen flare hypercalcemia: an additional support for gallium nitrate usage.
    Arumugam GP; Sundravel S; Shanthi P; Sachdanandam P
    J Bone Miner Metab; 2006; 24(3):243-7. PubMed ID: 16622738
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Clinical experience with tamoxifen in advanced breast cancer.
    Stoll BA
    Recent Results Cancer Res; 1980; 71():207-11. PubMed ID: 7367734
    [No Abstract]   [Full Text] [Related]  

  • 23. Endometrial carcinoma can develop in patients on tamoxifen therapy.
    Omar SZ; Sivanesaratnam V
    Med J Malaysia; 1999 Jun; 54(2):280-2. PubMed ID: 10972045
    [No Abstract]   [Full Text] [Related]  

  • 24. Antiestrogens and selective estrogen receptor modulators as multifunctional medicines. 2. Clinical considerations and new agents.
    Jordan VC
    J Med Chem; 2003 Mar; 46(7):1081-111. PubMed ID: 12646017
    [No Abstract]   [Full Text] [Related]  

  • 25. Hypercalcemic coma secondary to tamoxifen citrate.
    Valencic M; Woldenberg D; Kabakow B
    Mt Sinai J Med; 1979; 46(4):396-7. PubMed ID: 314575
    [No Abstract]   [Full Text] [Related]  

  • 26. Effect of tamoxifen treatment on estrogen metabolism in postmenopausal women with advanced breast cancer.
    Levin J; Markham MJ; Greenwald ES; O'Connor JF; Zumoff B; Fukushima DK
    Anticancer Res; 1982; 2(6):377-80. PubMed ID: 7168557
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Tamoxifen versus ethinyl estradiol in the treatment of postmenopausal women with advanced breast cancer.
    Beex L; Pieters G; Smals A; Koenders A; Benraad T; Kloppenborg P
    Cancer Treat Rep; 1981; 65(3-4):179-85. PubMed ID: 7237448
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Tamoxifen and hypercalcaemia.
    Daugaard G
    Ann Oncol; 1993 Sep; 4(8):683-7. PubMed ID: 8241000
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Clinical experiences with tamoxifen for estrogen receptor blocking therapy in metastatic breast cancer.
    Henningsen B
    Prog Clin Biol Res; 1977; 12():479-82. PubMed ID: 918118
    [No Abstract]   [Full Text] [Related]  

  • 30. Ovarian endometrioid carcinoma and endometriosis developing in a postmenopausal breast cancer patient during tamoxifen therapy: a case report and review of the literature.
    Cohen I; Altaras MM; Lew S; Tepper R; Beyth Y; Ben-Baruch G
    Gynecol Oncol; 1994 Dec; 55(3 Pt 1):443-7. PubMed ID: 7835785
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Predicting response to tamoxifen in metastatic breast cancer.
    Connor JL; Foley JF; Lemon HM
    Nebr Med J; 1986 Dec; 71(12):422-6. PubMed ID: 3796760
    [No Abstract]   [Full Text] [Related]  

  • 32. The significance of tumour "stimulation" by tamoxifen.
    Stoll BA
    Recent Results Cancer Res; 1980; 71():149-50. PubMed ID: 7367727
    [No Abstract]   [Full Text] [Related]  

  • 33. Hypercalcemia in patients with advanced mammary cancer and osseous metastases. Effect of hormone therapy and schedule of treatment.
    Donovan AJ; Bethune JE; Berne TV
    Am Surg; 1966 Oct; 32(10):673-80. PubMed ID: 5921429
    [No Abstract]   [Full Text] [Related]  

  • 34. [The modulators of the estrogenic activity].
    Kirkiacharian S
    Ann Pharm Fr; 2000 Dec; 58(6):383-91. PubMed ID: 11148373
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Tamoxifen and life-threatening hypercalcaemia.
    Spooner D; Evans BD
    Lancet; 1979 Aug; 2(8139):413-4. PubMed ID: 89466
    [No Abstract]   [Full Text] [Related]  

  • 36. Tamoxifen for breast cancer.
    Med Lett Drugs Ther; 1978 May; 20(9):41-2. PubMed ID: 642872
    [No Abstract]   [Full Text] [Related]  

  • 37. The nature of tamoxifen action in the control of female breast cancer.
    Kodama M; Kodama T
    In Vivo; 2001; 15(4):319-25. PubMed ID: 11695224
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Adenomyosis in postmenopausal breast cancer patients treated with tamoxifen: a new entity?
    Cohen I; Beyth Y; Tepper R; Figer A; Shapira J; Cordoba M; Yigael D; Altaras MM
    Gynecol Oncol; 1995 Jul; 58(1):86-91. PubMed ID: 7789896
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Paradoxical effects of tamoxifen on the woman's uterus. Apropos of 7 cases of myoma that appeared while under anti-estrogen treatment].
    Boudouris O; Ferrand S; Guillet JL; Madelenat P
    J Gynecol Obstet Biol Reprod (Paris); 1989; 18(3):372-8. PubMed ID: 2738326
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Tamoxifen treatment and new-onset depression in breast cancer patients.
    Lee KC; Ray GT; Hunkeler EM; Finley PR
    Psychosomatics; 2007; 48(3):205-10. PubMed ID: 17478588
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.